Skip to main content

3 Drug Stocks Poised to Surpass Estimates in Q2 Earnings

The pharma/biotech sector has picked up pace this year after being battered by the drug pricing controversy in 2016. The first half has been pretty strong for companies in the space.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.